YellowGrade
Pfizer in advanced talks to buy Global Blood Therapeutics for about $5 billion

Aug. 5, 2022, 1:18 p.m.

(FOX Business) The Wall Street Journal reports big pharma company Pfizer is looking to add sickle-cell disease drugmaker Global Blood Therapeutics to its pipeline.

Login to grade this article.